genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Neurological Disorders
New Optogenetic Tool May Find Application in Understanding Epileptic Seizures
Autism
Gut Microbiome Features Unrelated to Diet Linked to Autism Spectrum Disorder…
Autism
Significant Autism Risk from Ultra-Rare Inherited Genes
Cancer
Drug-Resistant Acute Lymphoblastic Leukemia and Relapse May Be Caused by Thiopurines
Antibodies
PerkinElmer to Acquire Antibody, Reagent Maker BioLegend for $5.25B
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Microsaic Systems Goes Real-Time with PAT
Bioprocessing
Know-How and Modeling Keys to Better Bioprocessing
Bioprocessing
Real-time Tools for Rapid Biomanufacturing Quality Control
Immunology
Multiomics Clinical Trial Compares Fermented and High-Fiber Diets
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Synthetic Biology Companies
A-Lists
Seven Up-and-Coming COVID-19 Drugs
A-Lists
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Orphan Drugs
Orphan Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan Drugs
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
Orphan Drugs
Fetal Gene Therapy Prevents Fatal Form of Gaucher Disease
Orphan Drugs
United Therapeutics to Acquire SteadyMed for Up to $216M
Orphan Drugs
Novartis to Acquire Gene Therapy Developer AveXis for $8.7B
Orphan Drugs
PhaseBio Wins $2.8M SBIR Grant to Advance Lead Candidate
Orphan Drugs
Erytech, Queen’s Partner to Develop Red Blood Cell-Encapsulated Enzyme Therapy
Orphan Drugs
FDA Commits to Eliminating Orphan Drug Backlog by September
Orphan Drugs
FDA Approves CSL Behring’s Self-Administered C1 Esterase Inhibitor HAE Prophylactic
Orphan Drugs
TeneoBio, Selexis Sign SUREtechnology Cell-Line Agreement for Anticancer UniAbs
Orphan Drugs
Mithra’s E4 Estrogen Wins EU Orphan Drug Designation for Treating HIE...
Orphan Drugs
Start-Up Firm Palladio to Repurpose Lixivaptan as Treatment for PKD
Orphan Drugs
Shire Plans Lanadelumab BLA Submission Following Positive Phase III HAE Results
Orphan Drugs
Synlogic, Mirna Agree to Stock-Based Merger to Focus on Synthetic Biotic...
Orphan Drugs
Ionis Antisense Drug Meets Primary Endpoints in Phase III FAP Study
Orphan Drugs
EC Clears EUSA’s Dinutuximab Beta for High-Risk Neuroblastoma in Children
1
2
3
Page 1 of 3
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
![CATZ study showed adding zonisamide to existing medications reduced frequency of seizures in children aged 6-17 years.[© ktsdesign - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug31_2011_7427959_BrainwithLightning_PosResultsEisaiPediatricEpilepsyDrug2437321111-218x150.jpg "New Optogenetic Tool May Find Application in Understanding Epileptic Seizures")
